Ran Salomon

570 total citations · 1 hit paper
9 papers, 397 citations indexed

About

Ran Salomon is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ran Salomon has authored 9 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ran Salomon's work include Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Ran Salomon is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Ran Salomon collaborates with scholars based in Israel, United States and Sweden. Ran Salomon's co-authors include Rony Dahan, Ido Amit, Tamar Farfel‐Becker, Anna Meshcheriakova, Mohammad Ali, Frances M. Platt, Anthony H. Futerman, Einat B. Vitner, Andrés D. Klein and Timothy M. Cox and has published in prestigious journals such as Cell, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Ran Salomon

9 papers receiving 387 citations

Hit Papers

Bispecific dendritic-T cell engager potentiates anti-tumo... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Salomon Israel 7 222 145 135 73 51 9 397
Xiaodong Zhu China 8 200 0.9× 137 0.9× 183 1.4× 13 0.2× 62 1.2× 19 461
Sandra Rollins United States 9 184 0.8× 193 1.3× 339 2.5× 18 0.2× 23 0.5× 10 534
Anselm Sommer Germany 10 74 0.3× 97 0.7× 209 1.5× 32 0.4× 29 0.6× 10 377
Roger Santimaria Switzerland 8 121 0.5× 69 0.5× 238 1.8× 45 0.6× 133 2.6× 18 449
Margarete Schön Germany 8 138 0.6× 146 1.0× 157 1.2× 23 0.3× 42 0.8× 8 399
Juergen Westermann Germany 8 337 1.5× 66 0.5× 79 0.6× 21 0.3× 21 0.4× 14 450
Chiara Cassioli Italy 12 112 0.5× 54 0.4× 153 1.1× 17 0.2× 81 1.6× 16 334
Enyu Ding United States 11 83 0.4× 51 0.4× 157 1.2× 116 1.6× 21 0.4× 11 349
Roberta Cariati Italy 13 63 0.3× 108 0.7× 209 1.5× 140 1.9× 76 1.5× 21 405
Akie Maehara Japan 11 278 1.3× 70 0.5× 164 1.2× 66 0.9× 28 0.5× 18 492

Countries citing papers authored by Ran Salomon

Since Specialization
Citations

This map shows the geographic impact of Ran Salomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Salomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Salomon more than expected).

Fields of papers citing papers by Ran Salomon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Salomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Salomon. The network helps show where Ran Salomon may publish in the future.

Co-authorship network of co-authors of Ran Salomon

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Salomon. A scholar is included among the top collaborators of Ran Salomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Salomon. Ran Salomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Itai, Y, Oren Barboy, Ran Salomon, et al.. (2024). Bispecific dendritic-T cell engager potentiates anti-tumor immunity. Cell. 187(2). 375–389.e18. 53 indexed citations breakdown →
2.
Yalin, Adam, Tomer Landsberger, Ran Salomon, et al.. (2023). Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy. Science Immunology. 8(81). eadd8005–eadd8005. 28 indexed citations
3.
Salomon, Ran, Yonatan Katzenelenbogen, Assaf Weiner, et al.. (2022). Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting. Nature Cancer. 3(3). 287–302. 53 indexed citations
4.
Salomon, Ran & Rony Dahan. (2022). Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy. Frontiers in Immunology. 13. 940674–940674. 42 indexed citations
5.
Pan, Xiaoyu, Eran Ophir, Zoya Alteber, et al.. (2019). Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity. Cancer Immunology Research. 7(2). 244–256. 45 indexed citations
6.
Biram, Adi, Anneli Strömberg, Eitan Winter, et al.. (2019). BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer’s patches. Nature Immunology. 20(4). 482–492. 40 indexed citations
7.
Liang, Spencer C., Ofer Levy, Sudipto Ganguly, et al.. (2017). Discovery of COM701, a therapeutic antibody targeting the novel immune checkpoint PVRIG, for the treatment of cancer.. Journal of Clinical Oncology. 35(15_suppl). 3074–3074. 5 indexed citations
8.
Vitner, Einat B., Ran Salomon, Tamar Farfel‐Becker, et al.. (2014). RIPK3 as a potential therapeutic target for Gaucher's disease. Nature Medicine. 20(2). 204–208. 130 indexed citations
9.
Salomon, Ran, Rogelio López‐Vélez, Francisco Pasquau, Javier Lafuente, & Paloma Gallar. (1983). [Lung cancer as a second primary cancer in patients with breast cancer. Presentation of 4 cases].. PubMed. 169(1). 51–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026